Advertisement
Telik, Inc. of Palo Alto, CA is a biopharmaceutical company focused ondiscovering, developing and commercializing novel small molecule drugs totreat serious diseases. The company's most advanced drug developmentcandidates are TELCYTA(R), a tumor-activated small molecule product candidatein clinical development for the treatment of advanced ovarian cancer andnon-small cell lung cancer; and TELINTRA(TM), which is in clinical developmentfor the treatment of myelodysplastic syndrome. Telik's product candidateswere discovered using its proprietary drug discovery technology, TRAP(TM),which enables the rapid and efficient discovery of small molecule drugcandidates.
SOURCE Telik, Inc.
